Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Imaging Technology Could Solve Childhood Disease Secrets

By BiotechDaily International staff writers
Posted on 14 Jan 2014
Image: A super-resolution optical image of a specific hRSV viral filament produced with dSTORM technology. The viral filament is approximately 4 microns in length, typical of hRSV (Photo courtesy of Eric Alonas and Philip Santangelo).
Image: A super-resolution optical image of a specific hRSV viral filament produced with dSTORM technology. The viral filament is approximately 4 microns in length, typical of hRSV (Photo courtesy of Eric Alonas and Philip Santangelo).
Image: Microscope image showing a cell infected with RSV. The RNA tagged by the probe is shown in red, while the nucleoprotein is green (Photo courtesy of Eric Alonas and Philip Santangelo).
Image: Microscope image showing a cell infected with RSV. The RNA tagged by the probe is shown in red, while the nucleoprotein is green (Photo courtesy of Eric Alonas and Philip Santangelo).
Most children, by the time they are two-years-old, have had respiratory syncytial virus (RSV) and suffered symptoms similar to a severe cold. However, for some children, in particular, for premature infants and those with underlying health problems, RSV can lead to pneumonia and bronchitis, which can require hospitalization and have long-term consequences.

A new technique for studying the structure of the RSV virion and the activity of RSV in living cells could help researchers solve the mysteries of the virus, including how it enters cells, how it replicates, how many genomes it inserts into its hosts, and possibly why specific lung cells escape the infection comparatively unharmed, which could provide scientists with the data they need to develop new antiviral drugs and perhaps even a vaccine to prevent severe RSV infections.

“We want to develop tools that would allow us to get at how the virus really works,” said Dr. Philip Santangelo, an associate professor in the Wallace H. Coulter department of biomedical engineering at Georgia Institute of Technology (Georgia Tech; Atlanta, GA, USA) and Emory University (Atlanta, GA, USA). “We really need to be able to follow the infection in a single living cell without affecting how the virus infects its hosts, and this technology should allow us to do that.”

The research was published online ahead of print in the journal ACS Nano on December 30, 2013. While RSV will be the first target for the work, the researchers believe the imaging technique they developed could be used to study other RNA viruses, including influenza and Ebolavirus. “We’ve shown that we can tag the genome using our probes,” explained Dr. Santangelo. “What we’ve learned from this is that the genome does get incorporated into the virion, and that the virus particles created are infectious. We were able to characterize some aspects of the virus particle itself at super-resolution, down to 20 nm, using direct stochastic optical reconstruction microscopy [dSTORM] imaging.”

RSV can be difficult to study. For one thing, the infectious particle can take different forms, ranging from 10-µm filaments to ordinary spheres. The virus can insert more than one genome into the host cells, and the RNA orientation and structure are disordered, which makes it difficult to characterize.

The research team, which included scientists from Vanderbilt University (Nashville, TN, USA) and Emory University, used a probe technology that quickly attaches to RNA within cells. The probe employs multiple fluorophores to indicate the presence of the viral RNA, allowing the researchers to see where it goes in host cells, and to view as infectious particles leave the cells to spread the infection. 

The research depended on a new method for labeling RNA viruses using multiply labeled tetravalent RNA imaging probes (MTRIPS). The probes consist of a chimeric combination of DNA and RNA oligonucleotide labeled internally with fluorophores tetravalently complexed to neutravidin. The chimeric combination was used to help the probes evade cellular defenses.

The probes, when introduced into cells, rapidly diffuse through a cell infected with RSV and bind to the virus’s RNA. Though binding tightly, the probe does not affect the normal activities of the virus and allows researchers to follow the activity for days using standard microscopy techniques. The MTRIPS can be used to complement other probe technology, such as green fluorescent protein (GFP) and gold nanoparticles.

To study the infection’s progress in individual cells, the researchers faced another challenge: living cells move around, and following them complicates the research. To tackle that movement, the laboratory of Thomas Barker, also from the Coulter department, used micropatterned fibronectin on glass to create 50-µm “islands” that contained the cells during the study.

Among the mysteries, that the researchers would like to solve is why certain lung cells are severely infected, while others appear to escape ill effects. “If you look at a field of cells, you see huge differences from cell to cell, and that is something that’s not understood at all,” Dr. Santangelo said. “If we can figure out why some cells are exploding with virus while others are not, perhaps we can figure out a way to help the bad ones look more like the good ones.”

Related Links:

Georgia Institute of Technology
Emory University
Vanderbilt University
 


comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.